| Promising targets for cancer immunotherapy: TLRs, RLRs, and STING-mediated innate immune pathways K Li, S Qu, X Chen, Q Wu, M Shi International journal of molecular sciences 18 (2), 404, 2017 | 179 | 2017 |
| Cancer-associated fibroblast–promoted lncRNA DNM3OS confers radioresistance by regulating DNA damage response in esophageal squamous cell carcinoma H Zhang, Y Hua, Z Jiang, J Yue, M Shi, X Zhen, X Zhang, L Yang, R Zhou, ... Clinical Cancer Research 25 (6), 1989-2000, 2019 | 129 | 2019 |
| Application potential of toll-like receptors in cancer immunotherapy: Systematic review M Shi, X Chen, K Ye, Y Yao, Y Li Medicine 95 (25), e3951, 2016 | 113 | 2016 |
| The Long Noncoding RNA MALAT1 Induces Tolerogenic Dendritic Cells and Regulatory T Cells via miR155/Dendritic Cell-Specific Intercellular Adhesion Molecule … J Wu, H Zhang, Y Zheng, X Jin, M Liu, S Li, Q Zhao, X Liu, Y Wang, M Shi, ... Frontiers in immunology 9, 1847, 2018 | 84 | 2018 |
| Targeting stem-loop 1 of the SARS-CoV-2 5′ UTR to suppress viral translation and Nsp1 evasion SM Vora, P Fontana, T Mao, V Leger, Y Zhang, TM Fu, J Lieberman, ... Proceedings of the National Academy of Sciences 119 (9), e2117198119, 2022 | 75 | 2022 |
| MAP1S controls breast cancer cell TLR5 signaling pathway and promotes TLR5 signaling-based tumor suppression M Shi, Y Yao, F Han, Y Li, Y Li PloS one 9 (1), e86839, 2014 | 40 | 2014 |
| MAP1S protein regulates the phagocytosis of bacteria and toll-like receptor (TLR) signaling M Shi, Y Zhang, L Liu, T Zhang, F Han, J Cleveland, F Wang, ... Journal of Biological Chemistry 291 (3), 1243-1250, 2016 | 31 | 2016 |
| Higher-order assemblies in innate immune and inflammatory signaling: A general principle in cell biology M Shi, P Zhang, SM Vora, H Wu Current opinion in cell biology 63, 194-203, 2020 | 26 | 2020 |
| Tumor‐derived peptidoglycan recognition protein 2 predicts survival and antitumor immune responses in hepatocellular carcinoma Z Yang, J Feng, L Xiao, X Chen, Y Yao, Y Li, Y Tang, S Zhang, M Lu, ... Hepatology 71 (5), 1626-1642, 2020 | 25 | 2020 |
| Biological and clinical significance of epigenetic silencing of MARVELD1 gene in lung cancer M Shi, S Wang, Y Yao, Y Li, H Zhang, F Han, H Nie, J Su, Z Wang, L Yue, ... Scientific reports 4 (1), 7545, 2014 | 22 | 2014 |
| Metabolic reprogramming orchestrates CD4+ T-cell immunological status and restores cardiac dysfunction in autoimmune induced-dilated cardiomyopathy mice J Wu, P Sun, Q Chen, Y Sun, M Shi, G Mang, S Yu, Y Zheng, Z Li, M Sun, ... Journal of Molecular and Cellular Cardiology 135, 134-148, 2019 | 20 | 2019 |
| Comprehensive characterization and evaluation of hepatocellular carcinoma by LC–MS based serum metabolomics X Lu, H Nie, Y Li, C Zhan, X Liu, X Shi, M Shi, Y Zhang, Y Li Metabolomics 11, 1381-1393, 2015 | 18 | 2015 |
| Transcriptome profiling unveils GAP43 regulates ABC transporters and EIF2 signaling in colorectal cancer cells X Chen, H Wu, J Feng, Y Li, J Lv, W Shi, W Fan, L Xiao, D Sun, M Jiang, ... BMC cancer 21, 1-10, 2021 | 16 | 2021 |
| MARVELD1 modulates cell surface morphology and suppresses epithelial–mesenchymal transition in non‐small cell lung cancer Y Yao, M Shi, S Liu, Y Li, K Guo, Y Ci, W Liu, Y Li Molecular carcinogenesis 55 (11), 1714-1727, 2016 | 16 | 2016 |
| MARVELD1 regulates integrin beta1-mediated cell adhesion and actin organization via inhibiting its pre-mRNA processing LY Wang S, Hu J, Yao Y, Shi M, Yue L, Han F, Zhang H, He J, Liu S Int J Biochem Cell Biol. 45 (11), 2679-2687, 2013 | 10 | 2013 |
| Inflammasome signaling: A novel paradigm of hub platform in innate immunity for cancer immunology and immunotherapy Y Li, J Lv, W Shi, J Feng, M Liu, S Gan, H Wu, W Fan, M Shi Frontiers in Immunology 12, 710110, 2021 | 8 | 2021 |
| Importin-β1 plays a key role in the nucleocytoplasmic transportation process of MARVELD1 ZY Wang, M Shi, Y Li Molecular Biology 49, 435-441, 2015 | 3 | 2015 |
| Immune normalization strategy against suboptimal health status: safe and efficacious therapy using mixed-natural killer cells Y Li, ODA Harunori, S Fu, F Xing, H Wu, J Wang, A Chen, X Ren, D Peng, ... Aging (Albany NY) 13 (16), 20131, 2021 | 2 | 2021 |
| TLR5 SIGNALING INDUCES AUTOPHAGIC CELL DEATH TO INHIBIT BREAST CANCER VIA NOVEL AUTOPHAGIC ADAPTOR MAP1S M Shi, Y Yao, Y Li CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY 40, 17-17, 2013 | | 2013 |
